关注
Carlos Serra Traynor
Carlos Serra Traynor
Associate Director, AstraZeneca
在 astrazeneca.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Imputing Biomarker Status from RWE Datasets—A Comparative Study
C Traynor, T Sahota, H Tomkinson, I Gonzalez-Garcia, N Evans, ...
Journal of Personalized Medicine 11 (12), 1356, 2021
22021
Longitudinal circulating tumor DNA modeling to predict disease progression in first‐line mutant epidermal growth factor receptor non‐small cell lung cancer
M Johnson, C Serra Traynor, K Vishwanathan, P Overend, R Hartmaier, ...
Clinical Pharmacology & Therapeutics 115 (2), 349-360, 2024
12024
Discovery and first disclosure of AZD8205, a B7-H4-targeted antibody-drug conjugate utilizing a novel topoisomerase I linker-warhead
K Kinneer, NJ Dickinson, L Masterson, T Cailleau, I Hutchinson, ...
Cancer Research 82 (12_Supplement), 1765-1765, 2022
12022
Analysing clinical data for real-world evidence generation in oncology
C Traynor
University of Warwick, 2021
2021
系统目前无法执行此操作，请稍后再试。
文章 1–4
共建清朗的网络空间,如遇有害信息,请举报。
本站数据皆整合自互联网公开资源索引,方便科研学术方面查询,并不存储相关数据资源;如对此有异议,请联系我们解决.
© 2023 学术资源搜索   @联系我们 | 申请短期会员 | 数据源提交